Vaccine Trials and Disease Burden Monitoring Underway in Africa
- Reports
- 5
- Developments
- 5
- Repetition
- 60%
New informationRepeats or wire copies
What happened
Vaccine trials are currently underway in Africa, alongside World Health Organization estimates regarding disease burden across the continent. These trials include the administration of a Merck vaccine in the Democratic Republic of the Congo, supported by the Coalition for Epidemic Preparedness Innovations. Furthermore, Texas Tech University Health Sciences Center is conducting trials for the SchistoShield vaccine in African locations. World Health Organization reports indicate that malaria remains a major public health challenge in Africa, claiming over 600,000 lives annually.
Why it matters
The ongoing trials highlight the need for sustained financing and local research leadership to strengthen vaccine development in low- and middle-income countries. The World Health Organization actively monitors and provides health guidance regarding disease burdens across Africa. The approval of the MVA-BN smallpox and mpox vaccine for children by the European Commission further expands access to non-replicating vaccines in the European Union.
Soligenix, Inc. collaborated with John A. Burns School of Medicine on vaccine development relevant for virus-endemic countries in Africa.
Who's involved
- World Health OrganizationMonitors disease burdens and provides health guidance across Africa
- Texas Tech University Health Sciences CenterLed the development and trials of the SchistoShield vaccine in Africa
- Democratic Republic of the CongoSite of a clinical trial for a Merck vaccine, monitored by the World Health Organization
- AfricaContinent where vaccine trials are being conducted and disease burdens are monitored
- West AfricaRegion of Africa where vaccine preparedness is being discussed
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- BangladeshSpeculative
The need for sustained financing to maintain local research capacity might increase government health expenditure in Bangladesh.
- Texas Tech University Health Sciences CenterSpeculative
Successful trials could increase institutional prestige and future grant funding access for Texas Tech University Health Sciences Center.
Possible ripples
Who this could reach next, traced step by step from the reporting. Possibilities worth considering, not forecasts.- New schistosomiasis vaccine trials boost Texas Tech University Health Sciences Center's profileSuccessful schistosomiasis vaccine trials could boost Texas Tech University Health Sciences Center's profileLikely
- Vaccine trials may improve African stability, influencing AfDB investmentsVaccine success could boost African economic stability, influencing AfDB lendingPossible
- Vaccine trials could support African Union's development goalsVaccine progress may support the African Union's health and development goalsPossible
How it developed
Newest first. Tap a step to see who reported it.IVI's Sahastrabuddhe discusses vaccine preparedness across West Africa and South Asia.1 source
- MMV is conducting clinical trials in Rwanda while WHO reports on malaria cases across Africa.Sub-event
- CEPI provided support for the Tumaini trial, where a Merck vaccine is being administered in the Democratic Republic of the Congo.Sub-event
- Texas Tech University led the development of the SchistoShield vaccine for schistosomiasis, conducting trials in African locations.Sub-event
Vaccine trials are underway in Africa, coinciding with WHO estimates of disease burden.1 source
Keep exploring
The entities involved
-
Africa
continent
-
World Health Organization
United Nations agency concerned with international public health